Dyax Corp. (NASDAQ:DYAX)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.
RSS Headlines
Fool UK
Recs
stock spam